Validation of the MuCopilot app for assessing cystic fibrosis
A Usability Validation of the MuCopilot Mobile Application, a Digital Tool for the Unsupervised Objective Assessment of Cystic Fibrosis
This study is testing a new app that helps people with cystic fibrosis check their lung function and exercise ability at home to see if it’s safe and easy to use.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 17 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Ad scientiam Academic / other |
| Locations | 1 site (Rouen) |
| Trial ID | NCT06132048 on ClinicalTrials.gov |
What this trial studies
This study evaluates the usability and safety of the MuCopilot mobile application, designed to objectively assess lung function and exercise capacity in patients with cystic fibrosis. Participants will use the app to perform unsupervised digital tests at home, collecting data on their condition between clinical visits. The study aims to ensure that patients can use the app effectively and safely, with a focus on minimizing errors and risks. A total of 17 patients will be involved, with assessments conducted in France.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older diagnosed with cystic fibrosis who can use a smartphone and understand French.
Not a fit: Patients with a history of lung transplantation or those unable to use a smartphone may not benefit from this study.
Why it matters
Potential benefit: If successful, this app could enhance the monitoring and management of cystic fibrosis, allowing for better patient outcomes.
How similar studies have performed: While the approach of using mobile applications for health monitoring is gaining traction, this specific validation of the MuCopilot app is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ⩾ 18 years old * Patients diagnosed with cystic fibrosis * Enrolled in or benefiting of a Social Security program * Having read the information sheet and signed the informed consent form * Owning a personal smartphone which version is above 14 for IOS and 8 for Android included with a good internet connexion * Able to read French and understand pictograms on a smartphone app Exclusion Criteria: * History of lung transplantation * Pregnant women and women who are breastfeeding * Any medical condition that could interfere with the proper conduct and results of the study (clinician's judgement) * Illiterate in French * Inability to use a smartphone or MuCopilot application * Person under legal protection (including guardianship or curatorship)
Where this trial is running
Rouen
- CRCM Mixte - Hôpital Charles Nicolle — Rouen, France (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.